Clinical features are unreliable for distinguishing ocular surface squamous neoplasia (OSSN) from benign conjunctival lesions.
To evaluate the adverse effects, accuracy, and interobserver variation of toluidine blue 0.05% vital staining in distinguishing OSSN, confirmed by histopathology, from other conjunctival lesions.
Design, Setting, and Participants...
JAMA Ophthalmol. Published online September 17, 2015. doi:10.1001/jamaophthalmol.2015.3345